Psychotische Dekompensation, Substanzkonsum oder serotonerges Syndrom?

Zusammenfassung Ein junger Patient mit paranoider Schizophrenie, Abhängigkeitserkrankung und schwerer depressiver Episode entwickelt ein serotonerges Syndrom während einer Kombinationsbehandlung mit Sertralin und Ziprasidon. Die korrekte diagnostische Einordnung der klinischen Symptome ist, obwohl häufig schwierig, von größter Bedeutung.

[1]  Nikhil Palekar,et al.  Serotonin syndrome with ziprasidone and sertraline. , 2013, The Journal of neuropsychiatry and clinical neurosciences.

[2]  C. Muhtz,et al.  Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial? , 2010, Journal of clinical psychopharmacology.

[3]  V. Arolt,et al.  The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  J. Amsterdam,et al.  Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. , 2007, Journal of Clinical Psychiatry.

[5]  Christo Minov.  QTc-Zeitverlängerung unter Ziprasidon in Kombination mit Quetiapin , 2004 .

[6]  M. Fava,et al.  Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. , 2004, The Journal of clinical psychiatry.

[7]  E. Spina,et al.  Metabolic drug interactions with new psychotropic agents , 2003, Fundamental & clinical pharmacology.

[8]  D. Sibbritt,et al.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. , 2003, QJM : monthly journal of the Association of Physicians.

[9]  Anne W. Schmidt,et al.  Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. , 2001, European journal of pharmacology.

[10]  H. Sternbach.  The serotonin syndrome. , 1991, The American journal of psychiatry.

[11]  L Lasagna,et al.  Adverse drug reactions. A critical review. , 1975, JAMA.